Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001442094 | SCV001645036 | likely benign | Hypertrophic cardiomyopathy | 2024-10-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001685356 | SCV001899906 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002420999 | SCV002718918 | likely benign | Cardiovascular phenotype | 2020-01-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV005403086 | SCV006063341 | likely benign | Cardiomyopathy | 2022-11-06 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005408904 | SCV006071217 | likely benign | not specified | 2025-03-31 | criteria provided, single submitter | clinical testing |